CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.43 -0.01 (-0.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) (2015 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Property, Plant & Equipment (Net) of $108.07 million for Q2 2026, down 13.5% from $124.93 million a year earlier and down 3.7% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

At the end of FY2025, CRISPR Therapeutics AG's Property, Plant & Equipment (Net) came in at $115.85 million, down 13.6% from FY2024.

  • Annual Property, Plant & Equipment (Net) has declined for three consecutive years, though with a five-year compound annual growth rate of 22.4% (FY2020 to FY2025).
  • In prior years, CRISPR Therapeutics AG's Property, Plant & Equipment (Net) was $134.09 million in FY2024 (-11.7%), $151.95 million in FY2023 (-7.1%), $163.63 million in FY2022 (+18.9%) and $137.58 million in FY2021 (+226.3%).
  • The Q2 2026 figure stands as the lowest quarterly Property, Plant & Equipment (Net) since Q3 2021.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last 13 quarters, with an average decline of 12.6% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was Q4 2021, with growth of 226.3%; the weakest was Q4 2025, with a decline of 13.6%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $112.18 million (Q1 2026), $115.85 million (Q4 2025) and $120.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 CRISPR Therapeutics AG 5.36 Bn 5.36 Bn - 108.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.07 Mn
Mar 31, 2026 112.18 Mn
Dec 31, 2025 115.85 Mn
Sep 30, 2025 120.83 Mn
Jun 30, 2025 124.93 Mn
Mar 31, 2025 129.43 Mn
Dec 31, 2024 134.09 Mn
Sep 30, 2024 138.54 Mn
Jun 30, 2024 143.03 Mn
Mar 31, 2024 147.25 Mn
Dec 31, 2023 151.95 Mn
Sep 30, 2023 156.12 Mn
Jun 30, 2023 159.17 Mn
Mar 31, 2023 162.20 Mn
Dec 31, 2022 163.63 Mn
Sep 30, 2022 166.11 Mn
Jun 30, 2022 165.19 Mn
Mar 31, 2022 157.45 Mn
Dec 31, 2021 137.58 Mn
Sep 30, 2021 105.88 Mn
API Access

CRISPR Therapeutics AG Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=CRSP&period=max&api_key=YOUR_API_KEY